Zobrazeno 1 - 4
of 4
pro vyhledávání: '"H. Gregory Moore"'
Autor:
Ryan A. Bartholomew, H. Gregory Moore, Henry H. Yin, Glenn D.R. Watson, Dongye Lu, Ryan N. Hughes, Haofang E. Li, Namsoo Kim, Min Tong Cai, Mark A. Rossi, Katrina A. Vokt
Publikováno v:
J Neurosci
Choice behavior is characterized by temporal discounting, i.e., preference for immediate rewards given a choice between immediate and delayed rewards. Agouti-related peptide (AgRP)-expressing neurons located in the arcuate nucleus of the hypothalamus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fbe95c6b5ec8d22cdf2d3416cf3dfe
https://europepmc.org/articles/PMC7939087/
https://europepmc.org/articles/PMC7939087/
Autor:
Dongye Lu, Haofang E. Li, Namsoo Kim, Mark A. Rossi, Katrina A. Vokt, Glenn W. Watson, Min Tong Cai, H. Gregory Moore, Ryan A. Bartholomew, Henry H. Yin
Choice behavior is characterized by temporal discounting, i.e., preference for immediate rewards over delayed rewards. Temporal discounting is often dysfunctional in psychiatric disorders, addiction, and eating disorders. However, the underlying neur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd227f0bab3f7db6bc85845c0a09d403
Autor:
Khaled Ajib, Gina M. Badalato, Douglas C. Cheung, Bilal Chughtai, Caroline Chung, Doreen E. Chung, Niall F. Davis, Erica L. Ditkoff, Dean Elterman, James C. Forde, Pierre-Alain Hueber, Steven Kaplan, Karthik R. Krishnan, Nathaniel D. Kwok, Matthew Lenardis, Michael J. Lipsky, Brady I. Magaoay, Malek Meskawi, Alexandra L. Millman, Carrie M. Mlynarczyk, H. Gregory Moore, Benjamin E. Muller, Cristina Negrean, Matthew P. Rutman, Zobia Shah, Alexander C. Small, Alexis Te, Dominique Thomas, Henry Tran, Stephanie Tsai, Roger Valdivieso, Sven J. Walderich, James P. Winebrake, Kevin C. Zorn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1244956d1aeb53a71483892d40c7505
https://doi.org/10.1016/b978-0-12-811464-3.01002-3
https://doi.org/10.1016/b978-0-12-811464-3.01002-3
Since the first urologic uses in the 1980s, laser has become a core component of benign prostatic hyperplasia with mounting evidence of their advantages from treating patients on anticoagulants to improved postoperative recovery times. There are thre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dac8d4bdf5dff9cdebf582c66a55700
https://doi.org/10.1016/b978-0-12-811464-3.00010-6
https://doi.org/10.1016/b978-0-12-811464-3.00010-6